
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
DACH1 CRISPR/Cas9 KO Plasmid (h) | sc-404712 | 20 µg | $397.00 |
DACH1 (dachshund family transcription factor 1) is a nuclear DNA-binding regulator implicated in cell fate decisions and tissue differentiation programs, with prominent roles in developmental signaling. In human cells, DACH1 modulates transcriptional networks linked to proliferation control, epithelial lineage maintenance, and cellular migration, including crosstalk with hormone receptor signaling and other transcription factor circuits. Altered DACH1 expression or regulatory activity has been associated with changes in tumor suppressive phenotypes, impacting processes such as cell-cycle progression, invasion, and metastasis-related gene expression. Its context-dependent function makes DACH1 a useful node for studying transcriptional repression/activation balance and pathway rewiring in disease-relevant models.
DACH1 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the DACH1 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the DACH1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the DACH1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish DACH1 protein expression.
This CRISPR knockout system enables efficient generation of DACH1-deficient cell models for investigation of DACH1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.